Manager × security

INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC REGN holdings history

Who else holds this security? →

REGENERON PHARMACEUTICALS · CUSIP 75886F107 · CIK 1818604

Some filings reported values in thousands; those figures were scaled ×1000 to dollars.
This is the oldest quarter open without an account, so changes against the quarter before it are withheld. Sign in to see them.
Citable facts

As of 2026-06-30, INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC reported 1.00K REGN (shares), valued at $625.45K, or 0.04% of its reported non-derivative portfolio. Filed 2026-07-22.

Verify history & sources →
Portfolio weight and quantity history
Reported portfolio weight
0.04%
Shares
1.00K
1,001
Reported value
$625.45K
USD

Shares increased 13.62%; reported value decreased 8.68%, and weight changed -0.01 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.

Left: % · Right: Shares · Independently scaled axes

Exact data and methodology

Axes scale independently; a crossing does not mean equal values. Weight uses each quarter's total reported non-derivative value. Same CUSIP; missing quarters are gaps, not zero. Revised history may include later disclosures.

QuarterWeightQuantitySource
Q2 20260.04%1,001SEC filing ↗Filed Jul 22, 2026
Q1 20260.05%881SEC filing ↗Filed May 1, 2026
Q4 20250.05%873SEC filing ↗Filed Feb 3, 2026
Q3 20250.03%728SEC filing ↗Filed Oct 31, 2025
Q2 20250.03%724SEC filing ↗Filed Jul 29, 2025
Q1 20250.03%557SEC filing ↗Filed Apr 23, 2025
Q4 20240.03%566SEC filing ↗Filed Jan 8, 2025
Q3 20241.28%880,939SEC filing ↗Filed Oct 22, 2024
Q2 20240.10%1,023SEC filing ↗Filed Jul 30, 2024
Q1 20240.07%736SEC filing ↗Filed Apr 11, 2024
Q4 20230.06%673SEC filing ↗Filed Jan 25, 2024Amended

History & evidence by quarter

QuarterWeightQuantityValueChange explainedSource
Q4 20230.06%673$591.09KThe prior quarter is outside the free window. Sign in for the comparison.SEC filing ↗
Filed Jan 25, 2024
Q1 20240.07%736$713.41KShares increased 9.36%; reported value increased 20.69%, and weight changed +0.01 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Apr 11, 2024
Q2 20240.10%1,023$1.08MShares increased 38.99%; reported value increased 50.71%, and weight changed +0.03 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Jul 30, 2024
Q3 20241.28%880,939$838.00MShares increased 86013.29%; reported value increased 77838.70%, and weight changed +1.18 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Oct 22, 2024
Q4 20240.03%566$404.80KShares decreased 99.94%; reported value decreased 99.95%, and weight changed -1.25 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Jan 8, 2025
Q1 20250.03%557$353.28KShares decreased 1.59%; reported value decreased 12.73%, and weight changed +0.00 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Apr 23, 2025
Q2 20250.03%724$380.13KShares increased 29.98%; reported value increased 7.60%, and weight changed +0.00 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Jul 29, 2025
Q3 20250.03%728$389.44KShares increased 0.55%; reported value increased 2.45%, and weight changed +0.00 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Oct 31, 2025
Q4 20250.05%873$673.93KShares increased 19.92%; reported value increased 73.05%, and weight changed +0.02 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 3, 2026
Q1 20260.05%881$684.87KShares increased 0.92%; reported value increased 1.62%, and weight changed +0.00 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 1, 2026
Q2 20260.04%1,001$625.45KShares increased 13.62%; reported value decreased 8.68%, and weight changed -0.01 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Jul 22, 2026
INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC · REGENERON PHARMACEUTICALS

Take these holdings further.

This page includes 11 of 11 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.

  • Download CSV
  • Earlier quarters
  • Advanced screening & filtering
  • API & AI access
Already have an account?

+ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.

MCP  https://api.akkrudata.ai/mcp

get_institutional_portfolio
{"cik":"1818604","quarter":"2026Q2","cusip":"75886F107"}

get_institutional_manager_history
{"cik":"1818604","page_size":100}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint
https://api.akkrudata.ai/mcp
API / MCP documentation
/documents
llms.txt
/llms.txt
Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

13F reports quarter-end long positions in securities traded on US exchanges, filed by managers holding at least $100 million of such securities; it is not the manager's full portfolio, not assets under management, and value changes are not returns. Weights use the reported total value as denominator. Option rows show notional value, not premium or net exposure. Amendments are merged into the quarter when Akkru could match them.